Written question asked by Lord Morris of Manchester (Labour), in the House of Lords. It was answered by Lord Warner (Labour) on Monday, 4 December 2006.
Health: Pfizer Products Distribution
- Question
- asked Her Majesty's Government:What representations they have received on the consequences for patients of Pfizer's decision, as the major supplier of medicines to the National Health Service, that from 5 March 2007 all its products will be distributed into the United Kingdom medical supply chain by one logistics service provider; and what action they will take to ensure patient safety.
- Answer
-
Since the announcement by Pfizer on 28 September 2006 of future changes to the distribution arrangements for its drugs, the department has received approximately 460 written representations concerned with this issue. Of these, 71 were from honourable Members and the remainder from pharmacists, wholesalers and the public. Additionally, there have been 10 House of Commons Parliamentary Questions on the issue. The department will monitor these new arrangements with a view to taking corrective action if appropriate.
Secondary information
- Type
- Written question
- Reference
- 174; 687 c96WA
- Session
- 2006-07
- Subjects
- Drugs Distribution NHS Procurement Pfizer
- Link
- View this Written question on www.publications.parliament.uk
Librarians' tools
- Timestamp
- 2022-06-01 12:29:11 +0100
- URI
- http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1191727
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1191727
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/pimsdata/Hansard/PARLIAMENTARY_QUESTION_1191727